❌

Normal view

There are new articles available, click to refresh the page.
Before yesterdayReuters - Business

Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients

By: Reuters
21 September 2026 at 10:46
Novo Nordisk said on Monday its next-generation experimental drug, CagriSema, delivered an β€Œestimated average weight loss of 12.4% in a late-stage trial in patients with diabetes, outperforming Eli Lilly's rival drug.

Warner Bros, Paramount rise on report California settlement talks could clear merger hurdle

By: Reuters
21 September 2026 at 10:08
Shares of Warner Bros Discovery and Paramount Skydance jumped on Monday, after a report said Paramount and California's attorney β€Œgeneral were in advanced settlement talks that could clear one of the final hurdles to the companies' $110 billion merger.
❌
❌